| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.31 | 6e-16 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-11 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-09 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.27 | 5e-05 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-05 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |